English
简体中文
Total: £ 56.28
Published Date: 2026-03-20 | Pages: 151 | Tables: 153 | Medical Devices & Consumables
The global Neurointerventional Guidewire market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Neurointerventional Guidewire competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Neurointerventional Guidewires are thin, flexible wire used in neurointerventional procedures to access and navigate through blood vessels in the brain and spinal cord. The wire is inserted through a catheter and carefully guided to the target site, serving as a pathway for placing other devices such as stents or coils.
The North American market for Neurointerventional Guidewire is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Neurointerventional Guidewire is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Neurointerventional Guidewire include Terumo Medical, Medtronic, Abbott Laboratories, Stryker, Penumbra, Merit Medical Systems, Boston Scientific, Integer Holdings Corporation, B. Braun Melsungen, Teleflex, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Neurointerventional Guidewire market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Neurointerventional Guidewire. The Neurointerventional Guidewire market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Neurointerventional Guidewire market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Neurointerventional Guidewire manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Terumo Medical
Medtronic
Abbott Laboratories
Stryker
Penumbra
Merit Medical Systems
Boston Scientific
Integer Holdings Corporation
B. Braun Melsungen
Teleflex
TE Connectivity
Johnson & Johnson
Smiths Group
Asahi Intecc
Cordis Corporation
Cook Medical
Lepu Meidcal
Scientia Vascular
FMD Co., Ltd.
Sino Medical Sciences Technology Inc.
MicroPort NeuroTech
Shanghai HeartCare Medical Technology Corporation Limited
Peijia Medical
Zhejiang Medical Devices Co., Ltd.
Shanghai Yingtai Medical Equipment
Beijing Taijieweiye Technology
Shunmei MEDICAL
Artiria Medical
Segment by Type
Stainless Steel Type
Alloy Type
Others
by Application
Hospitals
Clinic
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Neurointerventional Guidewire manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Neurointerventional Guidewire sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Neurointerventional Guidewire Market Overview
1.1 Product Definition
1.2 Neurointerventional Guidewire by Type
1.2.1 Global Neurointerventional Guidewire Market Value by Type: 2025 vs 2032
1.2.2 Stainless Steel Type
1.2.3 Alloy Type
1.2.4 Others
1.3 Neurointerventional Guidewire by Application
1.3.1 Global Neurointerventional Guidewire Market Value by Application: 2025 vs 2032
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Other
1.4 Global Neurointerventional Guidewire Market Size Estimates and Forecasts
1.4.1 Global Neurointerventional Guidewire Revenue 2021–2032
1.4.2 Global Neurointerventional Guidewire Sales 2021–2032
1.4.3 Global Neurointerventional Guidewire Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Neurointerventional Guidewire Market Competition by Manufacturers
2.1 Global Neurointerventional Guidewire Sales Market Share by Manufacturers (2021–2026)
2.2 Global Neurointerventional Guidewire Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Neurointerventional Guidewire Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Neurointerventional Guidewire, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Neurointerventional Guidewire, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Neurointerventional Guidewire, Product Types and Applications
2.7 Global Key Manufacturers of Neurointerventional Guidewire, Date of Entry into the Industry
2.8 Global Neurointerventional Guidewire Market Competitive Situation and Trends
2.8.1 Global Neurointerventional Guidewire Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Neurointerventional Guidewire Players Market Share by Revenue
2.8.3 Global Neurointerventional Guidewire Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Neurointerventional Guidewire Market Scenario by Region
3.1 Global Neurointerventional Guidewire Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Neurointerventional Guidewire Sales by Region: 2021–2032
3.2.1 Global Neurointerventional Guidewire Sales by Region: 2021–2026
3.2.2 Global Neurointerventional Guidewire Sales by Region: 2027–2032
3.3 Global Neurointerventional Guidewire Revenue by Region: 2021–2032
3.3.1 Global Neurointerventional Guidewire Revenue by Region: 2021–2026
3.3.2 Global Neurointerventional Guidewire Revenue by Region: 2027–2032
3.4 North America Neurointerventional Guidewire Market Facts & Figures by Country
3.4.1 North America Neurointerventional Guidewire Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Neurointerventional Guidewire Sales by Country (2021–2032)
3.4.3 North America Neurointerventional Guidewire Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Neurointerventional Guidewire Market Facts & Figures by Country
3.5.1 Europe Neurointerventional Guidewire Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Neurointerventional Guidewire Sales by Country (2021–2032)
3.5.3 Europe Neurointerventional Guidewire Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Neurointerventional Guidewire Market Facts & Figures by Region
3.6.1 Asia Pacific Neurointerventional Guidewire Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Neurointerventional Guidewire Sales by Region (2021–2032)
3.6.3 Asia Pacific Neurointerventional Guidewire Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Neurointerventional Guidewire Market Facts & Figures by Country
3.7.1 Latin America Neurointerventional Guidewire Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Neurointerventional Guidewire Sales by Country (2021–2032)
3.7.3 Latin America Neurointerventional Guidewire Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Neurointerventional Guidewire Market Facts & Figures by Country
3.8.1 Middle East and Africa Neurointerventional Guidewire Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Neurointerventional Guidewire Sales by Country (2021–2032)
3.8.3 Middle East and Africa Neurointerventional Guidewire Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Neurointerventional Guidewire Sales by Type (2021–2032)
4.1.1 Global Neurointerventional Guidewire Sales by Type (2021–2026)
4.1.2 Global Neurointerventional Guidewire Sales by Type (2027–2032)
4.1.3 Global Neurointerventional Guidewire Sales Market Share by Type (2021–2032)
4.2 Global Neurointerventional Guidewire Revenue by Type (2021–2032)
4.2.1 Global Neurointerventional Guidewire Revenue by Type (2021–2026)
4.2.2 Global Neurointerventional Guidewire Revenue by Type (2027–2032)
4.2.3 Global Neurointerventional Guidewire Revenue Market Share by Type (2021–2032)
4.3 Global Neurointerventional Guidewire Price by Type (2021–2032)
5 Segment by Application
5.1 Global Neurointerventional Guidewire Sales by Application (2021–2032)
5.1.1 Global Neurointerventional Guidewire Sales by Application (2021–2026)
5.1.2 Global Neurointerventional Guidewire Sales by Application (2027–2032)
5.1.3 Global Neurointerventional Guidewire Sales Market Share by Application (2021–2032)
5.2 Global Neurointerventional Guidewire Revenue by Application (2021–2032)
5.2.1 Global Neurointerventional Guidewire Revenue by Application (2021–2026)
5.2.2 Global Neurointerventional Guidewire Revenue by Application (2027–2032)
5.2.3 Global Neurointerventional Guidewire Revenue Market Share by Application (2021–2032)
5.3 Global Neurointerventional Guidewire Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Terumo Medical
6.1.1 Terumo Medical Company Information
6.1.2 Terumo Medical Description and Business Overview
6.1.3 Terumo Medical Neurointerventional Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Terumo Medical Neurointerventional Guidewire Product Portfolio
6.1.5 Terumo Medical Recent Developments/Updates
6.2 Medtronic
6.2.1 Medtronic Company Information
6.2.2 Medtronic Description and Business Overview
6.2.3 Medtronic Neurointerventional Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Medtronic Neurointerventional Guidewire Product Portfolio
6.2.5 Medtronic Recent Developments/Updates
6.3 Abbott Laboratories
6.3.1 Abbott Laboratories Company Information
6.3.2 Abbott Laboratories Description and Business Overview
6.3.3 Abbott Laboratories Neurointerventional Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Abbott Laboratories Neurointerventional Guidewire Product Portfolio
6.3.5 Abbott Laboratories Recent Developments/Updates
6.4 Stryker
6.4.1 Stryker Company Information
6.4.2 Stryker Description and Business Overview
6.4.3 Stryker Neurointerventional Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Stryker Neurointerventional Guidewire Product Portfolio
6.4.5 Stryker Recent Developments/Updates
6.5 Penumbra
6.5.1 Penumbra Company Information
6.5.2 Penumbra Description and Business Overview
6.5.3 Penumbra Neurointerventional Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Penumbra Neurointerventional Guidewire Product Portfolio
6.5.5 Penumbra Recent Developments/Updates
6.6 Merit Medical Systems
6.6.1 Merit Medical Systems Company Information
6.6.2 Merit Medical Systems Description and Business Overview
6.6.3 Merit Medical Systems Neurointerventional Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Merit Medical Systems Neurointerventional Guidewire Product Portfolio
6.6.5 Merit Medical Systems Recent Developments/Updates
6.7 Boston Scientific
6.7.1 Boston Scientific Company Information
6.7.2 Boston Scientific Description and Business Overview
6.7.3 Boston Scientific Neurointerventional Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Boston Scientific Neurointerventional Guidewire Product Portfolio
6.7.5 Boston Scientific Recent Developments/Updates
6.8 Integer Holdings Corporation
6.8.1 Integer Holdings Corporation Company Information
6.8.2 Integer Holdings Corporation Description and Business Overview
6.8.3 Integer Holdings Corporation Neurointerventional Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Integer Holdings Corporation Neurointerventional Guidewire Product Portfolio
6.8.5 Integer Holdings Corporation Recent Developments/Updates
6.9 B. Braun Melsungen
6.9.1 B. Braun Melsungen Company Information
6.9.2 B. Braun Melsungen Description and Business Overview
6.9.3 B. Braun Melsungen Neurointerventional Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 B. Braun Melsungen Neurointerventional Guidewire Product Portfolio
6.9.5 B. Braun Melsungen Recent Developments/Updates
6.10 Teleflex
6.10.1 Teleflex Company Information
6.10.2 Teleflex Description and Business Overview
6.10.3 Teleflex Neurointerventional Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Teleflex Neurointerventional Guidewire Product Portfolio
6.10.5 Teleflex Recent Developments/Updates
6.11 TE Connectivity
6.11.1 TE Connectivity Company Information
6.11.2 TE Connectivity Description and Business Overview
6.11.3 TE Connectivity Neurointerventional Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 TE Connectivity Neurointerventional Guidewire Product Portfolio
6.11.5 TE Connectivity Recent Developments/Updates
6.12 Johnson & Johnson
6.12.1 Johnson & Johnson Company Information
6.12.2 Johnson & Johnson Description and Business Overview
6.12.3 Johnson & Johnson Neurointerventional Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Johnson & Johnson Neurointerventional Guidewire Product Portfolio
6.12.5 Johnson & Johnson Recent Developments/Updates
6.13 Smiths Group
6.13.1 Smiths Group Company Information
6.13.2 Smiths Group Description and Business Overview
6.13.3 Smiths Group Neurointerventional Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Smiths Group Neurointerventional Guidewire Product Portfolio
6.13.5 Smiths Group Recent Developments/Updates
6.14 Asahi Intecc
6.14.1 Asahi Intecc Company Information
6.14.2 Asahi Intecc Description and Business Overview
6.14.3 Asahi Intecc Neurointerventional Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Asahi Intecc Neurointerventional Guidewire Product Portfolio
6.14.5 Asahi Intecc Recent Developments/Updates
6.15 Cordis Corporation
6.15.1 Cordis Corporation Company Information
6.15.2 Cordis Corporation Description and Business Overview
6.15.3 Cordis Corporation Neurointerventional Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Cordis Corporation Neurointerventional Guidewire Product Portfolio
6.15.5 Cordis Corporation Recent Developments/Updates
6.16 Cook Medical
6.16.1 Cook Medical Company Information
6.16.2 Cook Medical Description and Business Overview
6.16.3 Cook Medical Neurointerventional Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Cook Medical Neurointerventional Guidewire Product Portfolio
6.16.5 Cook Medical Recent Developments/Updates
6.17 Lepu Meidcal
6.17.1 Lepu Meidcal Company Information
6.17.2 Lepu Meidcal Description and Business Overview
6.17.3 Lepu Meidcal Neurointerventional Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Lepu Meidcal Neurointerventional Guidewire Product Portfolio
6.17.5 Lepu Meidcal Recent Developments/Updates
6.18 Scientia Vascular
6.18.1 Scientia Vascular Company Information
6.18.2 Scientia Vascular Description and Business Overview
6.18.3 Scientia Vascular Neurointerventional Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Scientia Vascular Neurointerventional Guidewire Product Portfolio
6.18.5 Scientia Vascular Recent Developments/Updates
6.19 FMD Co., Ltd.
6.19.1 FMD Co., Ltd. Company Information
6.19.2 FMD Co., Ltd. Description and Business Overview
6.19.3 FMD Co., Ltd. Neurointerventional Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 FMD Co., Ltd. Neurointerventional Guidewire Product Portfolio
6.19.5 FMD Co., Ltd. Recent Developments/Updates
6.20 Sino Medical Sciences Technology Inc.
6.20.1 Sino Medical Sciences Technology Inc. Company Information
6.20.2 Sino Medical Sciences Technology Inc. Description and Business Overview
6.20.3 Sino Medical Sciences Technology Inc. Neurointerventional Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.20.4 Sino Medical Sciences Technology Inc. Neurointerventional Guidewire Product Portfolio
6.20.5 Sino Medical Sciences Technology Inc. Recent Developments/Updates
6.21 MicroPort NeuroTech
6.21.1 MicroPort NeuroTech Company Information
6.21.2 MicroPort NeuroTech Description and Business Overview
6.21.3 MicroPort NeuroTech Neurointerventional Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.21.4 MicroPort NeuroTech Neurointerventional Guidewire Product Portfolio
6.21.5 MicroPort NeuroTech Recent Developments/Updates
6.22 Shanghai HeartCare Medical Technology Corporation Limited
6.22.1 Shanghai HeartCare Medical Technology Corporation Limited Company Information
6.22.2 Shanghai HeartCare Medical Technology Corporation Limited Description and Business Overview
6.22.3 Shanghai HeartCare Medical Technology Corporation Limited Neurointerventional Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.22.4 Shanghai HeartCare Medical Technology Corporation Limited Neurointerventional Guidewire Product Portfolio
6.22.5 Shanghai HeartCare Medical Technology Corporation Limited Recent Developments/Updates
6.23 Peijia Medical
6.23.1 Peijia Medical Company Information
6.23.2 Peijia Medical Description and Business Overview
6.23.3 Peijia Medical Neurointerventional Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.23.4 Peijia Medical Neurointerventional Guidewire Product Portfolio
6.23.5 Peijia Medical Recent Developments/Updates
6.24 Zhejiang Medical Devices Co., Ltd.
6.24.1 Zhejiang Medical Devices Co., Ltd. Company Information
6.24.2 Zhejiang Medical Devices Co., Ltd. Description and Business Overview
6.24.3 Zhejiang Medical Devices Co., Ltd. Neurointerventional Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.24.4 Zhejiang Medical Devices Co., Ltd. Neurointerventional Guidewire Product Portfolio
6.24.5 Zhejiang Medical Devices Co., Ltd. Recent Developments/Updates
6.25 Shanghai Yingtai Medical Equipment
6.25.1 Shanghai Yingtai Medical Equipment Company Information
6.25.2 Shanghai Yingtai Medical Equipment Description and Business Overview
6.25.3 Shanghai Yingtai Medical Equipment Neurointerventional Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.25.4 Shanghai Yingtai Medical Equipment Neurointerventional Guidewire Product Portfolio
6.25.5 Shanghai Yingtai Medical Equipment Recent Developments/Updates
6.26 Beijing Taijieweiye Technology
6.26.1 Beijing Taijieweiye Technology Company Information
6.26.2 Beijing Taijieweiye Technology Description and Business Overview
6.26.3 Beijing Taijieweiye Technology Neurointerventional Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.26.4 Beijing Taijieweiye Technology Neurointerventional Guidewire Product Portfolio
6.26.5 Beijing Taijieweiye Technology Recent Developments/Updates
6.27 Shunmei MEDICAL
6.27.1 Shunmei MEDICAL Company Information
6.27.2 Shunmei MEDICAL Description and Business Overview
6.27.3 Shunmei MEDICAL Neurointerventional Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.27.4 Shunmei MEDICAL Neurointerventional Guidewire Product Portfolio
6.27.5 Shunmei MEDICAL Recent Developments/Updates
6.28 Artiria Medical
6.28.1 Artiria Medical Company Information
6.28.2 Artiria Medical Description and Business Overview
6.28.3 Artiria Medical Neurointerventional Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.28.4 Artiria Medical Neurointerventional Guidewire Product Portfolio
6.28.5 Artiria Medical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Neurointerventional Guidewire Industry Chain Analysis
7.2 Neurointerventional Guidewire Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Neurointerventional Guidewire Production Mode & Process Analysis
7.4 Neurointerventional Guidewire Sales and Marketing
7.4.1 Neurointerventional Guidewire Sales Channels
7.4.2 Neurointerventional Guidewire Distributors
7.5 Neurointerventional Guidewire Customer Analysis
8 Neurointerventional Guidewire Market Dynamics
8.1 Neurointerventional Guidewire Industry Trends
8.2 Neurointerventional Guidewire Market Drivers
8.3 Neurointerventional Guidewire Market Challenges
8.4 Neurointerventional Guidewire Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Neurointerventional Guidewire Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Neurointerventional Guidewire Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Neurointerventional Guidewire Market Competitive Situation by Manufacturers in 2025
Table 4. Global Neurointerventional Guidewire Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Neurointerventional Guidewire Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Neurointerventional Guidewire Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Neurointerventional Guidewire Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Neurointerventional Guidewire Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Neurointerventional Guidewire, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Neurointerventional Guidewire, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Neurointerventional Guidewire, Product Types and Applications
Table 12. Global Key Manufacturers of Neurointerventional Guidewire, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Neurointerventional Guidewire Companies by Tier (Tier 1, Tier 2, Tier 3), based on Neurointerventional Guidewire Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Neurointerventional Guidewire Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Neurointerventional Guidewire Sales by Region (K Units), 2021–2026
Table 18. Global Neurointerventional Guidewire Sales Market Share by Region (2021–2026)
Table 19. Global Neurointerventional Guidewire Sales by Region (K Units), 2027–2032
Table 20. Global Neurointerventional Guidewire Sales Market Share by Region (2027–2032)
Table 21. Global Neurointerventional Guidewire Revenue by Region (US$ Million), 2021–2026
Table 22. Global Neurointerventional Guidewire Revenue Market Share by Region (2021–2026)
Table 23. Global Neurointerventional Guidewire Revenue by Region (US$ Million), 2027–2032
Table 24. Global Neurointerventional Guidewire Revenue Market Share by Region (2027–2032)
Table 25. North America Neurointerventional Guidewire Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Neurointerventional Guidewire Sales by Country (K Units), 2021–2026
Table 27. North America Neurointerventional Guidewire Sales by Country (K Units), 2027–2032
Table 28. North America Neurointerventional Guidewire Revenue by Country (US$ Million), 2021–2026
Table 29. North America Neurointerventional Guidewire Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Neurointerventional Guidewire Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Neurointerventional Guidewire Sales by Country (K Units), 2021–2026
Table 32. Europe Neurointerventional Guidewire Sales by Country (K Units), 2027–2032
Table 33. Europe Neurointerventional Guidewire Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Neurointerventional Guidewire Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Neurointerventional Guidewire Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Neurointerventional Guidewire Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Neurointerventional Guidewire Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Neurointerventional Guidewire Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Neurointerventional Guidewire Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Neurointerventional Guidewire Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Neurointerventional Guidewire Sales by Country (K Units), 2021–2026
Table 42. Latin America Neurointerventional Guidewire Sales by Country (K Units), 2027–2032
Table 43. Latin America Neurointerventional Guidewire Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Neurointerventional Guidewire Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Neurointerventional Guidewire Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Neurointerventional Guidewire Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Neurointerventional Guidewire Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Neurointerventional Guidewire Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Neurointerventional Guidewire Revenue by Country (US$ Million), 2027–2032
Table 50. Global Neurointerventional Guidewire Sales (K Units) by Type (2021–2026)
Table 51. Global Neurointerventional Guidewire Sales (K Units) by Type (2027–2032)
Table 52. Global Neurointerventional Guidewire Sales Market Share by Type (2021–2026)
Table 53. Global Neurointerventional Guidewire Sales Market Share by Type (2027–2032)
Table 54. Global Neurointerventional Guidewire Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Neurointerventional Guidewire Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Neurointerventional Guidewire Revenue Market Share by Type (2021–2026)
Table 57. Global Neurointerventional Guidewire Revenue Market Share by Type (2027–2032)
Table 58. Global Neurointerventional Guidewire Price (US$/Unit) by Type (2021–2026)
Table 59. Global Neurointerventional Guidewire Price (US$/Unit) by Type (2027–2032)
Table 60. Global Neurointerventional Guidewire Sales (K Units) by Application (2021–2026)
Table 61. Global Neurointerventional Guidewire Sales (K Units) by Application (2027–2032)
Table 62. Global Neurointerventional Guidewire Sales Market Share by Application (2021–2026)
Table 63. Global Neurointerventional Guidewire Sales Market Share by Application (2027–2032)
Table 64. Global Neurointerventional Guidewire Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Neurointerventional Guidewire Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Neurointerventional Guidewire Revenue Market Share by Application (2021–2026)
Table 67. Global Neurointerventional Guidewire Revenue Market Share by Application (2027–2032)
Table 68. Global Neurointerventional Guidewire Price (US$/Unit) by Application (2021–2026)
Table 69. Global Neurointerventional Guidewire Price (US$/Unit) by Application (2027–2032)
Table 70. Terumo Medical Company Information
Table 71. Terumo Medical Description and Business Overview
Table 72. Terumo Medical Neurointerventional Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Terumo Medical Neurointerventional Guidewire Product
Table 74. Terumo Medical Recent Developments/Updates
Table 75. Medtronic Company Information
Table 76. Medtronic Description and Business Overview
Table 77. Medtronic Neurointerventional Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Medtronic Neurointerventional Guidewire Product
Table 79. Medtronic Recent Developments/Updates
Table 80. Abbott Laboratories Company Information
Table 81. Abbott Laboratories Description and Business Overview
Table 82. Abbott Laboratories Neurointerventional Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Abbott Laboratories Neurointerventional Guidewire Product
Table 84. Abbott Laboratories Recent Developments/Updates
Table 85. Stryker Company Information
Table 86. Stryker Description and Business Overview
Table 87. Stryker Neurointerventional Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Stryker Neurointerventional Guidewire Product
Table 89. Stryker Recent Developments/Updates
Table 90. Penumbra Company Information
Table 91. Penumbra Description and Business Overview
Table 92. Penumbra Neurointerventional Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Penumbra Neurointerventional Guidewire Product
Table 94. Penumbra Recent Developments/Updates
Table 95. Merit Medical Systems Company Information
Table 96. Merit Medical Systems Description and Business Overview
Table 97. Merit Medical Systems Neurointerventional Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Merit Medical Systems Neurointerventional Guidewire Product
Table 99. Merit Medical Systems Recent Developments/Updates
Table 100. Boston Scientific Company Information
Table 101. Boston Scientific Description and Business Overview
Table 102. Boston Scientific Neurointerventional Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Boston Scientific Neurointerventional Guidewire Product
Table 104. Boston Scientific Recent Developments/Updates
Table 105. Integer Holdings Corporation Company Information
Table 106. Integer Holdings Corporation Description and Business Overview
Table 107. Integer Holdings Corporation Neurointerventional Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Integer Holdings Corporation Neurointerventional Guidewire Product
Table 109. Integer Holdings Corporation Recent Developments/Updates
Table 110. B. Braun Melsungen Company Information
Table 111. B. Braun Melsungen Description and Business Overview
Table 112. B. Braun Melsungen Neurointerventional Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. B. Braun Melsungen Neurointerventional Guidewire Product
Table 114. B. Braun Melsungen Recent Developments/Updates
Table 115. Teleflex Company Information
Table 116. Teleflex Description and Business Overview
Table 117. Teleflex Neurointerventional Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Teleflex Neurointerventional Guidewire Product
Table 119. Teleflex Recent Developments/Updates
Table 120. TE Connectivity Company Information
Table 121. TE Connectivity Description and Business Overview
Table 122. TE Connectivity Neurointerventional Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. TE Connectivity Neurointerventional Guidewire Product
Table 124. TE Connectivity Recent Developments/Updates
Table 125. Johnson & Johnson Company Information
Table 126. Johnson & Johnson Description and Business Overview
Table 127. Johnson & Johnson Neurointerventional Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Johnson & Johnson Neurointerventional Guidewire Product
Table 129. Johnson & Johnson Recent Developments/Updates
Table 130. Smiths Group Company Information
Table 131. Smiths Group Description and Business Overview
Table 132. Smiths Group Neurointerventional Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Smiths Group Neurointerventional Guidewire Product
Table 134. Smiths Group Recent Developments/Updates
Table 135. Asahi Intecc Company Information
Table 136. Asahi Intecc Description and Business Overview
Table 137. Asahi Intecc Neurointerventional Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. Asahi Intecc Neurointerventional Guidewire Product
Table 139. Asahi Intecc Recent Developments/Updates
Table 140. Cordis Corporation Company Information
Table 141. Cordis Corporation Description and Business Overview
Table 142. Cordis Corporation Neurointerventional Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 143. Cordis Corporation Neurointerventional Guidewire Product
Table 144. Cordis Corporation Recent Developments/Updates
Table 145. Cook Medical Company Information
Table 146. Cook Medical Description and Business Overview
Table 147. Cook Medical Neurointerventional Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 148. Cook Medical Neurointerventional Guidewire Product
Table 149. Cook Medical Recent Developments/Updates
Table 150. Lepu Meidcal Company Information
Table 151. Lepu Meidcal Description and Business Overview
Table 152. Lepu Meidcal Neurointerventional Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 153. Lepu Meidcal Neurointerventional Guidewire Product
Table 154. Lepu Meidcal Recent Developments/Updates
Table 155. Scientia Vascular Company Information
Table 156. Scientia Vascular Description and Business Overview
Table 157. Scientia Vascular Neurointerventional Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 158. Scientia Vascular Neurointerventional Guidewire Product
Table 159. Scientia Vascular Recent Developments/Updates
Table 160. FMD Co., Ltd. Company Information
Table 161. FMD Co., Ltd. Description and Business Overview
Table 162. FMD Co., Ltd. Neurointerventional Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 163. FMD Co., Ltd. Neurointerventional Guidewire Product
Table 164. FMD Co., Ltd. Recent Developments/Updates
Table 165. Sino Medical Sciences Technology Inc. Company Information
Table 166. Sino Medical Sciences Technology Inc. Description and Business Overview
Table 167. Sino Medical Sciences Technology Inc. Neurointerventional Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 168. Sino Medical Sciences Technology Inc. Neurointerventional Guidewire Product
Table 169. Sino Medical Sciences Technology Inc. Recent Developments/Updates
Table 170. MicroPort NeuroTech Company Information
Table 171. MicroPort NeuroTech Description and Business Overview
Table 172. MicroPort NeuroTech Neurointerventional Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 173. MicroPort NeuroTech Neurointerventional Guidewire Product
Table 174. MicroPort NeuroTech Recent Developments/Updates
Table 175. Shanghai HeartCare Medical Technology Corporation Limited Company Information
Table 176. Shanghai HeartCare Medical Technology Corporation Limited Description and Business Overview
Table 177. Shanghai HeartCare Medical Technology Corporation Limited Neurointerventional Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 178. Shanghai HeartCare Medical Technology Corporation Limited Neurointerventional Guidewire Product
Table 179. Shanghai HeartCare Medical Technology Corporation Limited Recent Developments/Updates
Table 180. Peijia Medical Company Information
Table 181. Peijia Medical Description and Business Overview
Table 182. Peijia Medical Neurointerventional Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 183. Peijia Medical Neurointerventional Guidewire Product
Table 184. Peijia Medical Recent Developments/Updates
Table 185. Zhejiang Medical Devices Co., Ltd. Company Information
Table 186. Zhejiang Medical Devices Co., Ltd. Description and Business Overview
Table 187. Zhejiang Medical Devices Co., Ltd. Neurointerventional Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 188. Zhejiang Medical Devices Co., Ltd. Neurointerventional Guidewire Product
Table 189. Zhejiang Medical Devices Co., Ltd. Recent Developments/Updates
Table 190. Shanghai Yingtai Medical Equipment Company Information
Table 191. Shanghai Yingtai Medical Equipment Description and Business Overview
Table 192. Shanghai Yingtai Medical Equipment Neurointerventional Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 193. Shanghai Yingtai Medical Equipment Neurointerventional Guidewire Product
Table 194. Shanghai Yingtai Medical Equipment Recent Developments/Updates
Table 195. Beijing Taijieweiye Technology Company Information
Table 196. Beijing Taijieweiye Technology Description and Business Overview
Table 197. Beijing Taijieweiye Technology Neurointerventional Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 198. Beijing Taijieweiye Technology Neurointerventional Guidewire Product
Table 199. Beijing Taijieweiye Technology Recent Developments/Updates
Table 200. Shunmei MEDICAL Company Information
Table 201. Shunmei MEDICAL Description and Business Overview
Table 202. Shunmei MEDICAL Neurointerventional Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 203. Shunmei MEDICAL Neurointerventional Guidewire Product
Table 204. Shunmei MEDICAL Recent Developments/Updates
Table 205. Artiria Medical Company Information
Table 206. Artiria Medical Description and Business Overview
Table 207. Artiria Medical Neurointerventional Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 208. Artiria Medical Neurointerventional Guidewire Product
Table 209. Artiria Medical Recent Developments/Updates
Table 210. Key Raw Materials Lists
Table 211. Raw Materials Key Suppliers Lists
Table 212. Neurointerventional Guidewire Distributors List
Table 213. Neurointerventional Guidewire Customers List
Table 214. Neurointerventional Guidewire Market Trends
Table 215. Neurointerventional Guidewire Market Drivers
Table 216. Neurointerventional Guidewire Market Challenges
Table 217. Neurointerventional Guidewire Market Restraints
Table 218. Research Programs/Design for This Report
Table 219. Key Data Information from Secondary Sources
Table 220. Key Data Information from Primary Sources
Table 221. Authors List of This Report
List of Figures
Figure 1. Product Picture of Neurointerventional Guidewire
Figure 2. Global Neurointerventional Guidewire Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Neurointerventional Guidewire Market Share by Type: 2025 & 2032
Figure 4. Stainless Steel Type Product Picture
Figure 5. Alloy Type Product Picture
Figure 6. Others Product Picture
Figure 7. Global Neurointerventional Guidewire Market Value by Application (US$ Million), 2021–2032
Figure 8. Global Neurointerventional Guidewire Market Share by Application: 2025 & 2032
Figure 9. Hospitals
Figure 10. Clinic
Figure 11. Other
Figure 12. Global Neurointerventional Guidewire Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Neurointerventional Guidewire Market Size (US$ Million), 2021–2032
Figure 14. Global Neurointerventional Guidewire Sales (K Units), 2021–2032
Figure 15. Global Neurointerventional Guidewire Average Price (US$/Unit), 2021–2032
Figure 16. Neurointerventional Guidewire Report Years Considered
Figure 17. Neurointerventional Guidewire Sales Share by Manufacturers in 2025
Figure 18. Global Neurointerventional Guidewire Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Neurointerventional Guidewire Players: Market Share by Revenue in Neurointerventional Guidewire in 2025
Figure 20. Neurointerventional Guidewire Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Neurointerventional Guidewire Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Neurointerventional Guidewire Sales Market Share by Country (2021–2032)
Figure 23. North America Neurointerventional Guidewire Revenue Market Share by Country (2021–2032)
Figure 24. United States Neurointerventional Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Neurointerventional Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Neurointerventional Guidewire Sales Market Share by Country (2021–2032)
Figure 27. Europe Neurointerventional Guidewire Revenue Market Share by Country (2021–2032)
Figure 28. Germany Neurointerventional Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Neurointerventional Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Neurointerventional Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Neurointerventional Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Neurointerventional Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Neurointerventional Guidewire Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Neurointerventional Guidewire Revenue Market Share by Region (2021–2032)
Figure 35. China Neurointerventional Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Neurointerventional Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Neurointerventional Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Neurointerventional Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Neurointerventional Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan Neurointerventional Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Southeast Asia Neurointerventional Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Latin America Neurointerventional Guidewire Sales Market Share by Country (2021–2032)
Figure 43. Latin America Neurointerventional Guidewire Revenue Market Share by Country (2021–2032)
Figure 44. Mexico Neurointerventional Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Brazil Neurointerventional Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Argentina Neurointerventional Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Colombia Neurointerventional Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Neurointerventional Guidewire Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Neurointerventional Guidewire Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Neurointerventional Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Neurointerventional Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE Neurointerventional Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Neurointerventional Guidewire by Type (2021–2032)
Figure 54. Global Revenue Market Share of Neurointerventional Guidewire by Type (2021–2032)
Figure 55. Global Neurointerventional Guidewire Price (US$/Unit) by Type (2021–2032)
Figure 56. Global Sales Market Share of Neurointerventional Guidewire by Application (2021–2032)
Figure 57. Global Revenue Market Share of Neurointerventional Guidewire by Application (2021–2032)
Figure 58. Global Neurointerventional Guidewire Price (US$/Unit) by Application (2021–2032)
Figure 59. Neurointerventional Guidewire Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
